Asciminib – the best treatment Lisa’s had in 16 years
Lisa McNeil is happy with the delayed decision she made in 2015 to go on a Phase I trial for a new CML drug – asciminib.Â
- Chronic myeloid leukaemia
Lisa McNeil is happy with the delayed decision she made in 2015 to go on a Phase I trial for a new CML drug – asciminib.Â